Skip to main content
. 2022 Jan;23(1):125–137. doi: 10.1016/S1470-2045(21)00470-8

Figure 2.

Figure 2

Event-free survival of patients in the per-protocol group in the titration trial and the embedded randomised trial

(A) Event-free survival of the patients in the per-protocol group in the titration trial, for patients with adequate response without radiotherapy (blue) and patients with inadequate response scheduled for radiotherapy (red). (B) Event-free survival of the patients in the per-protocol group in the embedded randomisation trial who were treated with COPP (red) and COPDAC (blue). COPP=cyclophosphamide, vincristine, prednisone, and procarbazine. COPDAC=cyclophosphamide, vincristine, prednisone, and dacarbazine.